Pretreatment of CT26 cells with the AhR-specific antagonist (CH223191) partially abolished the anti-cell-proliferative effect of El1405CS, indicating that the anti-CRC effect of El1405CS was associated with indole derivatives. The gene discussed is AHR; the disease is colorectal carcinoma.